Zentalis Pharmaceuticals Inc.
ZNTL | NASDAQ
$3.07
+$0.04 (+1.32%)
Sep 22, 2026, 11:02 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 26.87M | n/a | n/a | 40.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 151K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 324K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -151K | n/a | n/a | n/a | n/a | 26.87M | n/a | n/a | 40.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -82.25M | -37.86M | -37.39M | -33.73M | -36.06M | -45.62M | -49.85M | -51.43M | -65.15M | -24.77M | -67.92M | -62.72M | -103.92M | -64.95M | -51.75M | -54.19M | -63.46M | -57.88M | -48.19M | -62.87M | -55.13M | -50.35M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 493 | n/a | n/a | n/a | n/a | n/a | n/a | 143K |
Pretax Income | -77.38M | -35.23M | -34.77M | -26.69M | -26.87M | -48.28M | -47.68M | -40.19M | -88.01M | 10.18M | -61.07M | -55.51M | -113.17M | -63.15M | -55.34M | -54.66M | -68.38M | -59.2M | -49.94M | -11.19M | -55.02M | -50.25M |
Net Income | -77.64M | -35.35M | -35.22M | -26.69M | -26.87M | -48.28M | -47.47M | -40.16M | -88.28M | 10.07M | -60.92M | -55.53M | -112.53M | -63.22M | -54.97M | -54.4M | -68.36M | -59.08M | -50.06M | -4.19M | -54.57M | -49.9M |
Selling & General & Admin | 18.37M | 8.99M | 7.91M | 10.78M | 7.3M | 10.58M | 40.01M | 14.61M | 16.76M | 15.42M | 16.36M | 15.95M | 15.66M | 16.37M | 11.14M | 12.01M | 19.64M | 11.77M | 9.75M | 8.87M | 10.36M | 11.95M |
Research & Development | 63.88M | 28.72M | 29.49M | 22.95M | 27.61M | 27.25M | 32.97M | 36.82M | 48.39M | 49.59M | 51.56M | 46.77M | 42.68M | 48.58M | 40.62M | 42.18M | 43.83M | 46.11M | 38.44M | 54M | 44.77M | 38.39M |
Other Expenses | n/a | n/a | n/a | n/a | 1.15M | 7.8M | 3.74M | n/a | -1 | n/a | 1 | n/a | 45.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 82.25M | 37.7M | 37.39M | 33.73M | 36.06M | 45.62M | 76.71M | 51.43M | 65.15M | 65M | 67.92M | 62.72M | 103.92M | 64.95M | 51.75M | 54.19M | 63.46M | 57.88M | 48.19M | 62.87M | 55.13M | 50.35M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 345K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -151K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -324K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 82.25M | 37.86M | 37.39M | 33.73M | 36.06M | 45.62M | 76.71M | 51.43M | 65.15M | 65.33M | 67.92M | 62.72M | 103.92M | 64.95M | 51.75M | 54.19M | 63.46M | 57.88M | 48.19M | 62.87M | 55.13M | 50.35M |
Income Tax Expense | 258K | 120K | 442K | n/a | n/a | n/a | -205K | -27K | 266K | 143K | -135K | 31K | -605K | 108K | -360K | -159K | 17K | 33K | 159K | -697K | 45K | 196K |
Shares Outstanding (Basic) | 70.26M | 70.26M | 71.67M | 72.14M | 71.99M | 71.68M | 71.24M | 71.11M | 71.04M | 70.9M | 70.77M | 70.61M | 60.79M | 59.28M | 59.28M | 56.81M | 51.12M | 45.24M | 44.98M | 44.61M | 40.74M | 40.36M |
Shares Outstanding (Diluted) | 70.26M | 70.26M | 71.67M | 72.14M | 71.99M | 71.68M | 71.24M | 71.11M | 71.04M | 71.19M | 70.77M | 70.61M | 60.79M | 59.28M | 59.28M | 56.81M | 51.12M | 45.24M | 44.98M | 44.61M | 40.74M | 40.36M |
EPS (Basic) | -1.10 | -0.50 | -0.49 | -0.37 | -0.37 | -0.67 | -0.67 | -0.56 | -1.24 | 0.14 | -0.86 | -0.79 | -1.85 | -1.03 | -0.81 | -0.92 | -1.23 | -1.27 | -1.11 | -0.09 | -1.34 | -1.24 |
EPS (Diluted) | -1.10 | -0.50 | -0.49 | -0.37 | -0.37 | -0.67 | -0.67 | -0.56 | -1.24 | 0.14 | -0.86 | -0.79 | -1.85 | -1.03 | -0.81 | -0.92 | -1.23 | -1.27 | -1.11 | -0.09 | -1.34 | -1.24 |
EBITDA | -77.23M | -35.08M | -34.62M | -26.53M | -34.75M | -37.57M | -45.8M | -39.86M | -87.68M | 10.51M | -60.74M | -55.16M | -58M | -62.79M | -54.64M | -54.28M | -68.03M | -58.86M | -37.98M | -11.05M | -54.9M | -50.27M |
EBIT | -77.38M | -35.23M | -34.77M | -26.69M | -34.91M | -37.83M | -46.11M | -40.19M | -88.01M | 10.18M | -61.07M | -55.51M | -58.35M | -63.15M | -55M | -54.66M | -68.38M | -59.2M | -38.19M | -11.19M | -55.02M | -50.35M |
Depreciation & Amortization | 153K | 151K | 157K | 160K | 160K | 262K | 317K | 321K | 327K | 324K | 337K | 348K | 344K | 360K | 359K | 375K | 348K | 344K | 209K | 137K | 119K | 79K |
Add to Watchlist
Select watchlists to add or remove ZNTL